2017
DOI: 10.1002/ehf2.12228
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: AimsChronic obstructive pulmonary disease (COPD) and heart failure (HF) are increasingly frequent in Asia and commonly coexist in patients. However, the prevalence of COPD among Asian patients with HF and its impact on HF treatment are unclear.Methods and resultsWe compared clinical characteristics and treatment approaches between patients with or without a history of COPD, before and after 1:2 propensity matching (for age, sex, geographical region, income level, and ethnic group) in 5232 prospectively recruit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 11 publications
(26 citation statements)
references
References 33 publications
(36 reference statements)
1
25
0
Order By: Relevance
“…Because of concern regarding respiratory deterioration, the presence of COPD is an important cause of the underuse of beta-blockers. 3 Cardio-selective beta-blockers are usually recommended to avoid attenuation of the benefit of inhaled β 2 agonists 27 ; however, previous studies have revealed no association between selectivity and outcomes. 3,[12][13][14] Moreover, in a previous study, we reported that beta-blockers, including non-cardio-selective The crude and adjusted HRs for age, sex, BMI, systolic BP, and heart rate were calculated in reference to the group that did not receive beta-blockers.…”
Section: Treatment Of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Diseasementioning
confidence: 99%
See 2 more Smart Citations
“…Because of concern regarding respiratory deterioration, the presence of COPD is an important cause of the underuse of beta-blockers. 3 Cardio-selective beta-blockers are usually recommended to avoid attenuation of the benefit of inhaled β 2 agonists 27 ; however, previous studies have revealed no association between selectivity and outcomes. 3,[12][13][14] Moreover, in a previous study, we reported that beta-blockers, including non-cardio-selective The crude and adjusted HRs for age, sex, BMI, systolic BP, and heart rate were calculated in reference to the group that did not receive beta-blockers.…”
Section: Treatment Of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Diseasementioning
confidence: 99%
“…3 Cardio-selective beta-blockers are usually recommended to avoid attenuation of the benefit of inhaled β 2 agonists 27 ; however, previous studies have revealed no association between selectivity and outcomes. 3,[12][13][14] Moreover, in a previous study, we reported that beta-blockers, including non-cardio-selective The crude and adjusted HRs for age, sex, BMI, systolic BP, and heart rate were calculated in reference to the group that did not receive beta-blockers. The HR was calculated for the 2 year all-cause mortality, HF rehospitalization, and CV mortality.…”
Section: Treatment Of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…These studies could provide better understanding of the effect of the antidiabetes drugs on HF in patients with or without T2DM, and could potentiate to broaden the use of these drugs beyond their conventional therapeutic use. Moreover, many co-morbidities other than T2DM and prediabetes such as cachexia and muscle wasting, anaemia and iron deficiency, chronic obstructive pulmonary disease and sleep apnoea are also important in managing HF patients [44][45][46][47][48][49][50].…”
Section: Cardiovascular Outcomes With Sglt-2 Inhibitorsmentioning
confidence: 99%
“…This profile might be particularly advantageous for patients with heart disease and COPD with an asthmatic component and/or pulmonary arterial vasoconstriction. However, because there was no significant beneficial effect of nebivolol on mortality in a recent study with Asian patients [21], nebivolol was not recommended by all guidelines for chronic heart failure.
Fig. 1Beta receptors, their main function in cardiovascular and pulmonary physiology, and the most important beta-blockers for clinical use
…”
Section: Receptor Specificity and Route Of Applicationmentioning
confidence: 99%